|
k

Home
Application
Faculty
Rotations
Curriculum
Conferences
Manuals
Trainees
Coverage
Links
|
HMS Fellowship Program in Transfusion Medicine - Participating Faculty
Chance M. John Luckey, MD PhD
Instructor in Pathology
Harvard Medical School
Associate Medical Director, Joint Program in Transfusion Medicine
Brigham and Women's Hospital
Contact information
New Research Building 77 Avenue Louis Pasteur, Rm 652D
Boston, MA 02115
Phone: 617-525-4413
FAX: 617-525-4422
BWH pager: 39150
Education
BA, 1991, University of Georgia
MD PhD, 2001, University of Virginia
Clinical Pathology Residency, 2001-2004, Brigham and Women's Hospital
Fellow in Transfusion Medicine, 2004-2005, Harvard Joint Program in
Transfusion Medicine
Research Interests
Our group studies self-renewal in hematopoietic stem cells as well as memory T cells.
We are interested in discovering the molecular pathways employed by these cells that
allow them to live in our blood system for our lifetimes. In the case of hematopoietic
stem cells, their self-renewal is essential for the continued daily production of new blood
cells, and further serves as the basis for successful bone marrow transplantation. In the
case of memory T cells, their self-renewal is the basis of our bodies' ability to remember
previous infections, and serves as the basis for successful vaccination. In particular, we
develop and use mouse model systems to investigate the role of various signaling
molecules in stem cells and T cells.
A second focus of my lab will be to apply recent advances in highly-sensitive,
comparative, quantitative mass spectrometry to identify post-translational protein
modifications involved in self-renewal. Towards that end, we are using unbiased
phospho-proteomics to identify the changes in signaling pathways downstream of the
major self-renewal signals in mouse embryonic stem cells as well as memory T cells.
These proteomics studies are done in close collaboration with Jarrod Marto, director of
the Blias Proteomics Center at the Dana Farber Cancer Institute. Our proteomic findings
will be used to generate novel mouse model systems to further study the molecular
pathways involved in self-renewal.
Home
|
Application
|
Faculty
|
Rotations
|
Curriculum
|
Conferences
|
Manuals
|
Trainees
|
Coverage
|
Links
Homepage: http://www.harvardtransfusion.org
© 2005-2008 Harvard Medical School Fellowship Program in Transfusion
Medicine. All rights reserved.
|